NYSE:BIOLife Sciences
Is It Time To Reassess Bio-Rad Laboratories (BIO) After Its Recent 16% Weekly Surge?
If you are wondering whether Bio-Rad Laboratories at around US$287.74 is priced attractively or not, it helps to step back and look at what the recent share performance and valuation checks are really saying.
The stock has moved sharply, with a 16.2% gain over the past week, while returns for the past month and year to date are down 4.3% and down 5.7% respectively, and the 1 year return sits at 28.6% against declines of 24.1% over 3 years and 52.2% over 5 years.
These mixed returns sit...